Medindia

X

Abbott Laboratories to buy Biocompatibles' cardiovascular stent business

by Medindia Content Team on  April 16, 2002 at 2:30 PM Drug News   - G J E 4
Abbott Laboratories to buy Biocompatibles' cardiovascular stent business
Abbott Laboratories said it has agreed to acquire the cardiovascular stent business of Biocompatibles International PLC for $234.5 million in cash. Abbott said the deal will strengthen its portfolio of products and will expand its international presence in the vascular business for polymer-coated stents - tiny metal tubes that keep blood vessels open.
Advertisement

Abbott has been the exclusive U.S. distributor of the British company's BiodivYsio coated stents since 1999. The pharmaceutical and medical device manufacturer also will assume worldwide commercial rights for all potential drug-coated stent products in Biocompatibles' pipeline.

Advertisement
Abbott Laboratories said it expects the deal to be completed in the second quarter. Abbott shares fell 71 cents to $53.30 in trading on the New York Stock Exchange.
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All